Search

Your search keyword '"O'Connor, Christopher"' showing total 163 results

Search Constraints

Start Over You searched for: Author "O'Connor, Christopher" Remove constraint Author: "O'Connor, Christopher" Database Gale General OneFile Remove constraint Database: Gale General OneFile
163 results on '"O'Connor, Christopher"'

Search Results

1. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes

2. Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease

3. Spatial optimization of operationally relevant large fire confine and point protection strategies: model development and test cases

4. Endoplasmic reticulum-associated degradation is required for nephrin maturation and kidney glomerular filtration function

5. A Living Wage for Jamaica: Considerations for Calculation and Implementation

6. Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease

7. Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

8. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

9. A review of dyspnea in acute heart failure syndromes

10. The CheZ binding interface of Che[A.sub.s] is located in [alpha]-helix E

11. Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials

12. Conceptual hierarchies in a flat attractor network: dynamics of learning and computations

13. Coronary bypass surgery with or without surgical ventricular reconstruction

14. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial

15. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

17. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries

18. The pathophysiology of acute heart failure -- Is it all about fluid accumulation?

19. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure

20. Revascularization for heart failure

21. The new heart failure guidelines: Strategies for implementation

22. Heart Failure and A Controlled Trial Investigating Outcomes of Exercise traiNing (HF-ACTION): design and rationale

23. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)

24. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure

25. Predicting significant coronary artery disease in patients with left ventricular dysfunction

27. Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study

28. Anemia in patients with heart failure and preserved systolic function

29. Anemia in patients with heart failure and preserved systolic function

30. A cooperative network of trained sites for the conduct of a complex clinical trial: a new concept in multicenter clinical research

31. Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trial

32. Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced heart failure Regimens in the outpatient setting: BRain natrIuretic peptide versus the clinical congesTion scorE (STARBRITE) trial

33. Impact of the pulmonary artery catheter in critically ill patients: Meta-analysis of randomized clinical trials

34. Depression and ischemic heart disease: What have we learned so far and what must we do in the future?

36. Tezosentan in patients with acute heart failure: design of the value of endothelin receptor inhibition with tezosentan in acute heart failure study (VERITAS)

39. The accessibility of Cys-120 in CheA(sub s) is important for the binding of CheZ and enhancement of CheZ phosphatase activity

41. Training trials in heart failure: Time to exercise restraint?

42. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

43. Importance of echocardiography in patients with severe nonischemic heart failure: The second prospective randomized amlodipine survival evaluation(PRAISE-2) echocardiographic study

44. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: The Plavix use for treatment of congestive heart failure (PLUTO-CHF) trial

46. Azithromycin for the secondary prevention of coronary heart disease events: a randomized controlled trial

49. Vasopressin: A new target for the treatment of heart failure

50. Radionuclide viability testing: Should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?

Catalog

Books, media, physical & digital resources